These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 32735615
1. Prediction of Mycobacterium tuberculosis pyrazinamidase function based on structural stability, physicochemical and geometrical descriptors. Supo-Escalante RR, Médico A, Gushiken E, Olivos-Ramírez GE, Quispe Y, Torres F, Zamudio M, Antiparra R, Amzel LM, Gilman RH, Sheen P, Zimic M. PLoS One; 2020; 15(7):e0235643. PubMed ID: 32735615 [Abstract] [Full Text] [Related]
2. Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis. Sheen P, Ferrer P, Gilman RH, López-Llano J, Fuentes P, Valencia E, Zimic MJ. Tuberculosis (Edinb); 2009 Mar; 89(2):109-13. PubMed ID: 19249243 [Abstract] [Full Text] [Related]
6. Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran. Doustdar F, Pazhang M, Mehrnejad F, Safarzadeh M, Rabiei D, Chaparzadeh N, Falahati H, Mir-Derikvand M. Protein J; 2015 Jun; 34(3):181-92. PubMed ID: 25972249 [Abstract] [Full Text] [Related]
7. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance. Zimic M, Fuentes P, Gilman RH, Gutiérrez AH, Kirwan D, Sheen P. Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792 [Abstract] [Full Text] [Related]
8. Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase. Zhang H, Deng JY, Bi LJ, Zhou YF, Zhang ZP, Zhang CG, Zhang Y, Zhang XE. FEBS J; 2008 Feb; 275(4):753-62. PubMed ID: 18201201 [Abstract] [Full Text] [Related]
12. Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide. Petrella S, Gelus-Ziental N, Maudry A, Laurans C, Boudjelloul R, Sougakoff W. PLoS One; 2011 Jan 24; 6(1):e15785. PubMed ID: 21283666 [Abstract] [Full Text] [Related]
13. Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility. Vats C, Dhanjal J, Goyal S, Gupta A, Bharadvaja N, Grover A. BMC Genomics; 2015 Jan 24; 16 Suppl 2(Suppl 2):S14. PubMed ID: 25708048 [No Abstract] [Full Text] [Related]
14. Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants. Jagadeb M, Rath SN, Sonawane A. J Cell Biochem; 2018 Sep 24; 119(9):7328-7338. PubMed ID: 29761826 [Abstract] [Full Text] [Related]
16. Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis. Lemaitre N, Callebaut I, Frenois F, Jarlier V, Sougakoff W. Biochem J; 2001 Feb 01; 353(Pt 3):453-8. PubMed ID: 11171040 [Abstract] [Full Text] [Related]
19. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Scorpio A, Zhang Y. Nat Med; 1996 Jun 01; 2(6):662-7. PubMed ID: 8640557 [Abstract] [Full Text] [Related]